Colony Capital (NYSE:CLNY) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a research report issued to clients and investors on Tuesday. The firm presently has a $6.75 price objective on the real estate investment trust’s stock. Zacks Investment Research‘s price objective would suggest a potential upside of 15.78% from the stock’s current price.

According to Zacks, “Colony Capital, Inc. is a real estate and investment management firm. The company focused on investing in real estate and real estate-related assets. It serves health care, industrial and hospitality sectors. The company also offers equity and debt management services. Colony Capital Inc., formerly known as Colony NorthStar Inc., is based in Los Angeles, United States. “

Separately, ValuEngine raised shares of Colony Capital from a “sell” rating to a “hold” rating in a research note on Monday, July 2nd.

Colony Capital stock opened at $5.83 on Tuesday. Colony Capital has a 1 year low of $5.28 and a 1 year high of $12.75. The company has a debt-to-equity ratio of 1.00, a current ratio of 3.68 and a quick ratio of 3.68.

Colony Capital (NYSE:CLNY) last released its quarterly earnings results on Wednesday, August 8th. The real estate investment trust reported ($0.19) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.28). Colony Capital had a negative net margin of 14.25% and a negative return on equity of 3.87%. The company had revenue of $689.60 million during the quarter, compared to analyst estimates of $660.51 million. During the same period in the prior year, the business posted $0.35 EPS. Colony Capital’s revenue was up 1.5% compared to the same quarter last year. On average, analysts predict that Colony Capital will post 0.6 earnings per share for the current fiscal year.

Institutional investors have recently added to or reduced their stakes in the stock. Timbercreek Investment Management Inc. boosted its stake in Colony Capital by 7.0% during the 3rd quarter. Timbercreek Investment Management Inc. now owns 1,284,726 shares of the real estate investment trust’s stock worth $7,824,000 after purchasing an additional 84,450 shares during the last quarter. Fondren Management LP acquired a new stake in Colony Capital during the 2nd quarter worth $2,995,000. Northern Trust Corp acquired a new stake in Colony Capital during the 2nd quarter worth $34,430,000. FMR LLC acquired a new stake in Colony Capital during the 2nd quarter worth $144,070,000. Finally, Schroder Investment Management Group acquired a new stake in Colony Capital during the 2nd quarter worth $416,000. 81.19% of the stock is currently owned by hedge funds and other institutional investors.

Colony Capital Company Profile

Colony Capital, Inc (NYSE: CLNY) is a leading global investment management firm with assets under management of $43 billion. The company manages capital on behalf of its stockholders, as well as institutional and retail investors in private funds, non-traded and traded real estate investment trusts and registered investment companies.

Read More: How Do You Calculate Return on Equity (ROE)?

Get a free copy of the Zacks research report on Colony Capital (CLNY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Colony Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colony Capital and related companies with MarketBeat.com's FREE daily email newsletter.